Get started
Author

Jon H. Heinrichs

Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection
2001 · Theresa M. Wizemann, Jon H. Heinrichs, et al. · Infection and Immunity · 351
Identification and Characterization of a Novel Family of Pneumococcal Proteins That Are Protective against Sepsis
2001 · John E. Adamou, Jon H. Heinrichs, et al. · Infection and Immunity · 222
The molecular architecture of the sar locus in Staphylococcus aureus
1996 · M G Bayer, J H Heinrichs, et al. · Journal of Bacteriology · 185
Characterization of the sar locus and its interaction with agr in Staphylococcus aureus
1996 · J H Heinrichs, M G Bayer, et al. · Journal of Bacteriology · 150
sar Genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus
1997 · A L Cheung, M G Bayer, et al. · Journal of Bacteriology · 132
Molecular cloning and characterization of the hblA gene encoding the B component of hemolysin BL from Bacillus cereus
1993 · J H Heinrichs, D J Beecher, et al. · Journal of Bacteriology · 128
Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus
1997 · A L Cheung, K Eberhardt, et al. · Infection and Immunity · 122
RSV disease in infants and young children: Can we see a brighter future?
2022 · Eugenio Baraldi, Giovanni Checcucci Lisi, et al. · Human Vaccines & Immunotherapeutics · 99
PDF
Effect of Alternative Aluminum Adjuvants on the Absorption and Immunogenicity of HPV16 L1 VLPs in Mice
2007 · Michael J. Caulfield, Li Shi, et al. · Human Vaccines · 86
Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
2011 · Julie M. Skinner, Lani Indrawati, et al. · Vaccine · 82
Identification and Characterization of SirA, an Iron-Regulated Protein from Staphylococcus aureus
1999 · Jon H. Heinrichs, LaVette E. Gatlin, et al. · Journal of Bacteriology · 72
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
2018 · Maryann Giel-Moloney, Ana P. Goncalvez, et al. · Scientific Reports · 46
PDF
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains
2017 · Susan Secore, Su Wang, et al. · PLoS ONE · 37
PDF
Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation
2010 · Julie M. Skinner, Ivette C. Caro-Aguilar, et al. · Microbial Pathogenesis · 29
Development of a recombinant toxin fragment vaccine for Clostridium difficile infection
2014 · Jerzy Karczewski, Julie Zorman, et al. · Vaccine · 26
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197
2013 · Ivette Caro-Aguilar, Elizabeth Ottinger, et al. · Human Vaccines & Immunotherapeutics · 25
PDF
Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain
2017 · Ivette Caro-Aguilar, Lani Indrawati, et al. · Vaccine · 23
An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile
2014 · Matthew Miezeiewski, Todd Schnaufer, et al. · The ISME Journal · 21
PDF
An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques
2020 · Valérie Lecouturier, Vincent Pavot, et al. · npj Vaccines · 19
PDF
A real-time quantitative polymerase chain reaction assay for the detection of Chlamydia in the mouse genital tract model
2008 · Melissa A. Wooters, Robin M. Kaufhold, et al. · Diagnostic Microbiology and Infectious Disease · 19
Development and Optimization of a High-Throughput Assay To Measure Neutralizing Antibodies against Clostridium difficile Binary Toxin
2014 · Jinfu Xie, Melanie Horton, et al. · Clinical and Vaccine Immunology · 18
PDF
Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model
2020 · A. Ramakrishnan, S.S. Joseph, et al. · Vaccine · 17
Development and Optimization of a Novel Assay To Measure Neutralizing Antibodies against Clostridium difficile Toxins
2013 · Jinfu Xie, Julie Zorman, et al. · Clinical and Vaccine Immunology · 17
Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant
2014 · Bei Wang, Su Wang, et al. · Vaccine · 16
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
2020 · David Poncet, Catherine Hessler, et al. · npj Vaccines · 14
PDF
Works count: 50
Citation count: 2,032
H-index: 19
I10-index: 28
Year
Topic
Type